nifedipine has been researched along with Retinal Diseases in 11 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Retinal Diseases: Diseases involving the RETINA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study if the endogenous renin-angiotensin system affects diabetic retinal leukostasis, rats with streptozotocin-induced diabetes were treated with an ACE inhibitor (ramipril), an angiotensin II AT(1) receptor antagonist (losartan) and the Ca channel blocker, (nifedipine)." | 7.73 | Role of angiotensin II in retinal leukostasis in the diabetic rat. ( Chen, P; Dahl, D; Edwards, PA; Fenstermacher, JD; Guo, M; Scicli, AG; Scicli, GM, 2006) |
| "To study if the endogenous renin-angiotensin system affects diabetic retinal leukostasis, rats with streptozotocin-induced diabetes were treated with an ACE inhibitor (ramipril), an angiotensin II AT(1) receptor antagonist (losartan) and the Ca channel blocker, (nifedipine)." | 3.73 | Role of angiotensin II in retinal leukostasis in the diabetic rat. ( Chen, P; Dahl, D; Edwards, PA; Fenstermacher, JD; Guo, M; Scicli, AG; Scicli, GM, 2006) |
| "Nifedipine-treated cells also showed a decrease in cytosolic cytochrome c release and a decrease in caspase 3 activation, compared to cells treated only with Rec-1 antibody." | 1.33 | Anti-recoverin antibodies induce an increase in intracellular calcium, leading to apoptosis in retinal cells. ( Adamus, G; Duvoisin, RM; Shiraga, S; Webb, S, 2006) |
| "We report 2 patients with sickle cell anemia who showed retroequatorial localized red retinal lesions." | 1.27 | Retroequatorial red retinal lesions in sickle cell anemia. ( Noguchi, CT; Rodgers, GP; Roy, MS; Schechter, AN, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuroki, T | 1 |
| Mori, A | 1 |
| Nakahara, T | 1 |
| Sakamoto, K | 1 |
| Ishii, K | 1 |
| Fang, L | 1 |
| Turtschi, S | 1 |
| Mozaffarieh, M | 1 |
| Oguro, H | 1 |
| Saito, Y | 1 |
| Chidlow, G | 1 |
| Schmidt, KG | 1 |
| Wood, JP | 1 |
| Melena, J | 1 |
| Osborne, NN | 1 |
| Adamus, G | 1 |
| Webb, S | 1 |
| Shiraga, S | 1 |
| Duvoisin, RM | 1 |
| Chen, P | 1 |
| Scicli, GM | 1 |
| Guo, M | 1 |
| Fenstermacher, JD | 1 |
| Dahl, D | 1 |
| Edwards, PA | 1 |
| Scicli, AG | 1 |
| Winterkorn, JM | 1 |
| Kupersmith, MJ | 1 |
| Wirtschafter, JD | 1 |
| Forman, S | 1 |
| Ohguro, H | 1 |
| Ogawa, K | 1 |
| Maeda, T | 1 |
| Maruyama, I | 1 |
| Maeda, A | 1 |
| Takano, Y | 1 |
| Nakazawa, M | 1 |
| Crosson, CE | 1 |
| Willis, JA | 1 |
| Potter, DE | 1 |
| Gasser, P | 1 |
| Flammer, J | 1 |
| Mahler, F | 1 |
| Roy, MS | 1 |
| Rodgers, GP | 1 |
| Noguchi, CT | 1 |
| Schechter, AN | 1 |
1 review available for nifedipine and Retinal Diseases
| Article | Year |
|---|---|
[Paraneoplastic retinopathy].
Topics: Antibodies, Neoplasm; Autoantibodies; Calcium Channel Blockers; HSC70 Heat-Shock Proteins; Humans; N | 2008 |
10 other studies available for nifedipine and Retinal Diseases
| Article | Year |
|---|---|
Histological protection by nilvadipine against neurotoxicity induced by NOC12, a nitric oxide donor, in the rat retina.
Topics: Animals; Antioxidants; Excitatory Amino Acid Agonists; Male; N-Methylaspartate; Neuroprotective Agen | 2014 |
The effect of nifedipine on retinal venous pressure of glaucoma patients with the Flammer-Syndrome.
Topics: Administration, Oral; Aged; Blood Flow Velocity; Blood Pressure; Calcium Channel Blockers; Endotheli | 2015 |
Alpha-lipoic acid protects the retina against ischemia-reperfusion.
Topics: Anesthetics, Local; Animals; Antioxidants; Binding, Competitive; Brain-Derived Neurotrophic Factor; | 2002 |
Anti-recoverin antibodies induce an increase in intracellular calcium, leading to apoptosis in retinal cells.
Topics: Animals; Antibodies, Monoclonal; Apoptosis; Autoantibodies; bcl-2-Associated X Protein; bcl-X Protei | 2006 |
Role of angiotensin II in retinal leukostasis in the diabetic rat.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; A | 2006 |
Brief report: treatment of vasospastic amaurosis fugax with calcium-channel blockers.
Topics: Adult; Aged; Blindness; Carotid Stenosis; Embolism; Female; Humans; Male; Middle Aged; Nifedipine; R | 1993 |
Retinal dysfunction in cancer-associated retinopathy is improved by Ca(2+) antagonist administration and dark adaptation.
Topics: Animals; Antibodies; Antigens, Neoplasm; Calcium Channel Blockers; Calcium-Binding Proteins; Dark Ad | 2001 |
Effect of the calcium antagonist, nifedipine, on ischemic retinal dysfunction.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Electroretinography; Female; Isch | 1990 |
[The use of calcium antagonists in the treatment of ocular circulation symptoms in the framework of a vasospastic syndrome].
Topics: Calcium Channel Blockers; Humans; Nifedipine; Raynaud Disease; Retinal Diseases; Vasoconstriction; V | 1988 |
Retroequatorial red retinal lesions in sickle cell anemia.
Topics: Adult; Anemia, Sickle Cell; Fluorescein Angiography; Humans; Male; Nifedipine; Retinal Diseases | 1987 |